Brandon Mahal, M.D./NEJM Study (VIDEO) Dana-Farber Cancer Institute This video is under embargo. Please login to access this video. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video Caption Brandon Mahal, M.D. explains the difference in treatment pattern when it comes to active surveillance in African-American men with low-risk prostate cancer. He says this study demonstrates a need for more clinical research. Credit Dana-Farber Cancer Institute Usage Restrictions Please courtesy Dana-Farber Cancer Institute License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.